HEATHER WILSON: Open Payments
NPI 1831731298 · PATON, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$224 in 12 payments from 9 companies in 2025. Trend: 2023 $59 · 2024 $341 · 2025 $224
Food & beverage: $224
| Company | Payments | Amount |
|---|---|---|
| Organogenesis Inc. | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Alkermes, Inc. | 2 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| Tris Pharma Inc | 1 | $17 |
| Corium, LLC | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
Products named: REXULTI, NOVACHOR, ARISTADA, CAPLYTA, TRINTELLIX, INGREZZA, APLIGRAF, Azstarys.
Industry payments across IA — which companies pay providers there.
